A/Prof Ingrid Hopper is a clinical pharmacologist and general physician, and completed her PhD and post-doctoral research fellowship at Monash University School of Public Health and Preventive Medicine. She is a researcher at the Department of Epidemiology and Preventive Medicine at Monash University, and a consultant physician at the Alfred Hospital.

Her research covers diverse areas of therapeutics. She is principal investigator on the NHMRC funded STAREE-HEART study investigating whether statins prevent heart failure and atrial fibrillation in healthy elders, an ancillary study of the STAtins in Reducing Events in the Elderly (STAREE) study which is the largest randomised clinical trial currently recruiting in Australia. Previously she was project lead at the Australian Breast Device Registry, a Commonwealth funded national clinical quality registry performing post-market surveillance on breast implants, tissue expanders and dermal mesh.

She has published extensively, and her work has been recognized with multiple awards. Her research interests include cardiovascular therapeutics, heart failure and atrial fibrillation, healthy ageing, post-market surveillance of high risk implantable medical devices, clinical trials, registry science and epidemiology.